Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Nathan Grubaugh and John Fournier.
Nathan Grubaugh
Connection Strength
0.797
John Fournier
  1. SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity. Med (N Y). 2021 Mar 12; 2(3):263-280.e6.
    View in: PubMed
    Score: 0.230
  2. Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT-qPCR primer-probe sets. Nat Microbiol. 2020 10; 5(10):1299-1305.
    View in: PubMed
    Score: 0.223
  3. Maternal respiratory SARS-CoV-2 infection in pregnancy is associated with a robust inflammatory response at the maternal-fetal interface. Med (N Y). 2021 May 14; 2(5):591-610.e10.
    View in: PubMed
    Score: 0.059
  4. Stability of SARS-CoV-2 RNA in Nonsupplemented Saliva. Emerg Infect Dis. 2021 04; 27(4):1146-1150.
    View in: PubMed
    Score: 0.059
  5. Increased SARS-CoV-2 Testing Capacity with Pooled Saliva Samples. Emerg Infect Dis. 2021 04; 27(4).
    View in: PubMed
    Score: 0.059
  6. SARS-CoV-2 infection of the placenta. J Clin Invest. 2020 09 01; 130(9):4947-4953.
    View in: PubMed
    Score: 0.056
  7. Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2. N Engl J Med. 2020 09 24; 383(13):1283-1286.
    View in: PubMed
    Score: 0.056
  8. Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19. BMC Neurol. 2020 Jun 18; 20(1):248.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.